The European Commission said on Tuesday that it had signed a joint procurement contract for an antiviral treatment for patients with COVID-19 with Gilead Sciences Inc.
The European Union executive said it was the second contract for this therapeutic, the first having ended in April. It added in a statement that 22 EU member states and countries are participating in the joint procurement, under which they can purchase up to 2,250,000 vials.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
SNAP recertification in February 2026 is mandatory to keep food stamps active. Missing forms or…
Nintendo Switch has officially become the best-selling console in Nintendo history, beating the Nintendo DS…
February 2026 brings several buy-points promotions and bonus offers across major travel rewards programs, giving…
Punxsutawney Phil is famous for predicting winter or early spring, but official weather data shows…
The Australian Open men’s singles winner receives the Norman Brookes Challenge Cup, a historic silver…
Carlos Alcaraz earned $2.7 million in prize money for winning the 2026 Australian Open men’s…